Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Babylon Holdings Limited BBLN NYSE

NYSE • Healthcare • Medical - Healthcare Information Services • GB • USD

SharesGrow Score
23/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Babylon Holdings Limited (BBLN) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is neutral — 1 Buy, 2 Hold, 1 Sell.

BBLN Analyst Ratings

Hold
4
Ratings
1 Buy
2 Hold
1 Sell
Based on 4 analysts giving stock ratings to Babylon Holdings Limited in the past 3 months
Rating breakdown
Buy
1 25%
Hold
2 50%
Sell
1 25%
25%
Buy
1 analysts
50%
Hold
2 analysts
25%
Sell
1 analysts

People Also View

NUTX
NUTX
Nutex Health, Inc.
$107.84
+1.48%
 BEAT
BEAT
HeartBeam, Inc.
$1.20
+0.42%
 SNCE
SNCE
Science 37 Holdings, Inc.
$5.75
+0.35%
 LIFW
LIFW
MSP Recovery, Inc.
$3.24
+0.00%
 EUDA
EUDA
EUDA Health Holdings Limited
$6.88
+1.03%
 BFRG
BFRG
Bullfrog AI Holdings, Inc. Common Stock
$1.01
-3.81%
 ETAO
ETAO
ETAO International Co., Ltd.
$1.91
-31.79%
 HLTH
HLTH
Cue Health Inc.
$0.04
-29.77%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message